Willow Biosciences (TSE: WLLO- OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive with news the company has announced plans to commercially launch their proprietary yeast strain for the production of THC for Cannabis 2.0.
Peters talks about the research that has gone into this and that it’s odourless and flavourless attributes will make a strong core ingredient to produce products with. Peters also shares the timeline for this product to be available.
Price: 1.39 CAD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Willow Biosciences Inc. named herein, including the promotion by the Company of Willow Biosciences Inc. in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE
Willows BioSciences (TSX: WLLW- OTCQX: CANSF) CEO Trevor Peters joined Steve Darling from Proactive with news the company has selected its commercial manufacturing organization to produce its first CBG multi-kilogram run scheduled in Q1 2021. Peters telling Proactive this move is 6 months...
Basic Materials
Prev article
